Functional Benefits of Implants Placed During Ablative Surgery: A 5-year Prospective Study on the Prosthodontic Rehabilitation of 56 Edentulous Oral Cancer Patients
Overview
Authors
Affiliations
Background: The timing of placement as well as the functional benefit of interforaminal implants in edentulous patients treated for oral cancer is unclear.
Methods: Fifty-six patients were recruited at 2 institutions. In 1 institution, interforaminal implants were placed during ablative surgery, the other institution used conventional prosthodontics with optional placement of implants postsurgery (postponed-placement). Masticatory performance, bite force, and subjective masticatory function were assessed before and 6 months, 1 year, and 5 years after surgery.
Results: Implant-retained overdentures (IODs) demonstrated the highest bite force and the least problems with solid food and food choice. Masticatory performance was equal for IODs and conventional dentures. After 5 years, IODs from patients in the during-ablative-surgery cohort tend to have higher bite force and masticatory performance than those from patients in the postponed-placement cohort.
Conclusion: IODs produce the highest overall masticatory function. Implant placement during ablative surgery seems to be functionally beneficial. © 2016 Wiley Periodicals, Inc. Head Neck 38: E2103-E2111, 2016.
What is the evidence on the added value of implant-supported overdentures? A review.
Van de Winkel T, Heijens L, Listl S, Meijer G Clin Implant Dent Relat Res. 2021; 23(4):644-656.
PMID: 34268866 PMC: 8457103. DOI: 10.1111/cid.13027.
Alberga J, Korfage A, Bonnema I, Witjes M, Vissink A, Raghoebar G Support Care Cancer. 2020; 28(12):5911-5918.
PMID: 32279135 PMC: 7686200. DOI: 10.1007/s00520-020-05431-y.
Alberga J, Vosselman N, Korfage A, Delli K, Witjes M, Raghoebar G Oral Dis. 2020; 27(1):94-110.
PMID: 32097511 PMC: 7818452. DOI: 10.1111/odi.13312.
Brands M, Smeekens E, Takes R, Kaanders J, Verbeek A, Merkx M Cancer Med. 2019; 8(12):5810-5819.
PMID: 31400079 PMC: 6745868. DOI: 10.1002/cam4.2124.
de Groot R, Merkx M, Hamann M, Brand H, de Haan A, Rosenberg A Support Care Cancer. 2019; 28(3):1491-1501.
PMID: 31273502 PMC: 6989568. DOI: 10.1007/s00520-019-04913-y.